Skip to main content Help with accessibility Skip to main navigation

March 2022 updates to the website

The website has now been updated following March's LSCMMG

The following Items have been updated and added to the website following the latest Strategic Commissioning Committee (SCC) Meeting:

Trixeo Aerosphere - a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (COPD) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2-agonist or combination of a long-acting beta2-agonist and a long-acting muscarinic antagonist

Bevespi Aerosphere - a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD)

Cenobamate - treating focal onset seizures in epilepsy (NICE TA753)

Solriamfetol - for treating excessive daytime sleepiness caused by narcolepsy (NICE TA758)

The following Items will be updated and added to the website following the next Strategic Commissioning Committee (SCC) Meeting:

Fremanezumab - preventing migraine (NICE TA764)

Upadacitinib - treating active psoriatic arthritis after inadequate response to DMARDs (NICE TA768)

Palforzia - treating peanut allergy in children and young people (NICE TA769)

Progesterone capsules (Utrogestan) - Progestogenic opposition of oestrogen HRT in women with an intact uterus